Connecticut 2017 Regular Session

Connecticut Senate Bill SB00552 Compare Versions

OldNewDifferences
1-General Assembly Substitute Bill No. 552
2-January Session, 2017 *_____SB00552PH____032817____*
1+General Assembly Committee Bill No. 552
2+January Session, 2017 LCO No. 4430
3+ *04430SB00552PH_*
4+Referred to Committee on PUBLIC HEALTH
5+Introduced by:
6+(PH)
37
48 General Assembly
59
6-Substitute Bill No. 552
10+Committee Bill No. 552
711
812 January Session, 2017
913
10-*_____SB00552PH____032817____*
14+LCO No. 4430
15+
16+*04430SB00552PH_*
17+
18+Referred to Committee on PUBLIC HEALTH
19+
20+Introduced by:
21+
22+(PH)
1123
1224 AN ACT CONCERNING A STANDING ORDER PROGRAM FOR DISPENSING OPIOID ANTAGONISTS.
1325
1426 Be it enacted by the Senate and House of Representatives in General Assembly convened:
1527
16-Section 1. (NEW) (Effective October 1, 2017) (a) A prescribing practitioner, as defined in section 20-14c of the general statutes, who is authorized to prescribe an opioid antagonist, as defined in section 17a-714a of the general statutes, may issue a standing order to a pharmacist licensed under part II of chapter 400j of the general statutes, enabling the pharmacist to dispense an opioid antagonist that is (1) administered by an intranasal application delivery system or an auto-injection delivery system, (2) approved by the federal Food and Drug Administration, and (3) dispensed by a pharmacist to any person at risk of experiencing an overdose of an opioid drug, as defined in 42 CFR 8.2, or to a family member, friend or other person in a position to assist a person at risk of experiencing an overdose of an opioid drug. Any such standing order shall be deemed issued for a legitimate medical purpose in the usual course of the prescribing practitioner's professional practice. For purposes of this section and section 20-633c of the general statutes, as amended by this act, "standing order" means, an agreement between a prescribing practitioner and a pharmacist whereby the prescribing practitioner issues a nonpatient specific prescription that enables the pharmacist to dispense an opioid antagonist that is administered by an intranasal application delivery system or an auto-injection delivery system and approved by the federal Food and Drug Administration.
28+Section 1. (NEW) (Effective October 1, 2017) (a) A prescribing practitioner, as defined in section 20-14c of the general statutes, who is authorized to prescribe an opioid antagonist, as defined in section 17a-714a of the general statutes, may prescribe, by standing order issued to a pharmacist licensed under part II of chapter 400j of the general statutes, an opioid antagonist that is (1) administered by an intranasal application delivery system or an auto-injection delivery system, (2) approved by the federal Food and Drug Administration, and (3) dispensed by a pharmacist to any person at risk of experiencing an overdose of an opioid drug, as defined in 42 CFR 8.2, or to a family member, friend or other person in a position to assist a person at risk of experiencing an overdose of an opioid drug. Any such prescription shall be deemed issued for a legitimate medical purpose in the usual course of the prescribing practitioner's professional practice. For purposes of this section and section 20-633c of the general statutes, as amended by this act, "standing order" means a nonpatient specific prescription for an opioid antagonist that is administered by an intranasal application delivery system or an auto-injection delivery system and approved by the federal Food and Drug Administration.
1729
1830 (b) A pharmacist who agrees to accept a standing order issued under subsection (a) of this section and dispenses an opioid antagonist in accordance with the provisions of said subsection shall be deemed not to have violated any standard of care for a pharmacist.
1931
2032 Sec. 2. Section 20-633c of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2017):
2133
2234 (a) (1) A person who is licensed as a pharmacist under part II of this chapter and is certified in accordance with subsection (b) of this section may prescribe, in good faith, an opioid antagonist, as defined in section 17a-714a. Such pharmacist shall [(1)] (A) provide appropriate training regarding the administration of such opioid antagonist to the person to whom the opioid antagonist is dispensed, and [(2)] (B) maintain a record of such dispensing and the training required pursuant to this chapter.
2335
24-(2) A person who is licensed as a pharmacist under part II of this chapter and is certified in accordance with subsection (b) of this section may dispense, in good faith, an opioid antagonist, as defined in section 17a-714a, that is administered by an intranasal application delivery system or an auto-injection delivery system, pursuant to a standing order issued under section 1 of this act. Such pharmacist shall (A) provide appropriate training regarding the administration of such opioid antagonist to the person to whom the opioid antagonist is dispensed, and (B) maintain a record of such dispensing and the training required pursuant to this chapter.
36+(2) A person who is licensed as a pharmacist under part II of this chapter may dispense, in good faith, an opioid antagonist, as defined in section 17a-714a, that is administered by an intranasal application delivery system or an auto-injection delivery system, pursuant to a standing order issued under section 1 of this act. Such pharmacist shall (A) provide appropriate training regarding the administration of such opioid antagonist to the person to whom the opioid antagonist is dispensed, and (B) maintain a record of such dispensing and the training required pursuant to this chapter.
2537
2638 (b) A pharmacist may only prescribe or dispense an opioid antagonist pursuant to this section if the pharmacist has been trained and certified by a program approved by the Commissioner of Consumer Protection.
2739
2840 (c) A pharmacist who prescribes or dispenses an opioid antagonist in compliance with this section shall be deemed not to have violated any standard of care for a pharmacist.
2941
3042 (d) The provisions of this section shall apply only to a pharmacist certified in accordance with subsection (b) of this section. No pharmacist may delegate or direct any other person to prescribe or dispense an opioid antagonist or train any person in the administration of such opioid antagonist pursuant to the provisions of subsection (a) of this section.
3143
3244 (e) The Commissioner of Consumer Protection may adopt regulations, in accordance with chapter 54, to implement the provisions of this section.
3345
3446
3547
3648
3749 This act shall take effect as follows and shall amend the following sections:
3850 Section 1 October 1, 2017 New section
3951 Sec. 2 October 1, 2017 20-633c
4052
4153 This act shall take effect as follows and shall amend the following sections:
4254
4355 Section 1
4456
4557 October 1, 2017
4658
4759 New section
4860
4961 Sec. 2
5062
5163 October 1, 2017
5264
5365 20-633c
5466
55-Statement of Legislative Commissioners:
67+Statement of Purpose:
5668
57-In Section 2(a)(2), "and is certified in accordance with subsection (b) of this section" was inserted after "chapter" for consistency with other provisions of the section.
69+To allow pharmacists to dispense opioid antagonists pursuant to a standing order issued by a prescribing practitioner.
70+
71+[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]
5872
5973
6074
61-PH Joint Favorable Subst.
75+Co-Sponsors: SEN. KENNEDY, 12th Dist.
6276
63-PH
77+Co-Sponsors:
6478
65-Joint Favorable Subst.
79+SEN. KENNEDY, 12th Dist.
80+
81+S.B. 552